Your browser doesn't support javascript.
loading
Nitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity.
Landge, Sudhir; Ramachandran, Vasanthi; Kumar, Anupriya; Neres, João; Murugan, Kannan; Sadler, Claire; Fellows, Mick D; Humnabadkar, Vaishali; Vachaspati, Prakash; Raichurkar, Anandkumar; Sharma, Sreevalli; Ravishankar, Sudha; Guptha, Supreeth; Sambandamurthy, Vasan K; Balganesh, Tanjore S; Ugarkar, Bheemarao G; Balasubramanian, V; Bandodkar, Balachandra S; Panda, Manoranjan.
Afiliação
  • Landge S; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Ramachandran V; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Kumar A; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Neres J; Global Health Institute, École Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland.
  • Murugan K; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Sadler C; iMED Safety Assessment, AstraZeneca, Alderley Park, Macclesfield, SK10 4TF, UK.
  • Fellows MD; iMED Safety Assessment, AstraZeneca, Alderley Park, Macclesfield, SK10 4TF, UK.
  • Humnabadkar V; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Vachaspati P; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Raichurkar A; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Sharma S; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Ravishankar S; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Guptha S; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Sambandamurthy VK; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Balganesh TS; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Ugarkar BG; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Balasubramanian V; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Bandodkar BS; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India.
  • Panda M; iMED Infection, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, 560024, India. manapanda@gmail.com.
ChemMedChem ; 11(3): 331-9, 2016 Feb 04.
Article em En | MEDLINE | ID: mdl-26751718
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzotiazóis / Mutagênicos / Mycobacterium tuberculosis / Nitrocompostos / Antituberculosos Idioma: En Revista: ChemMedChem Assunto da revista: FARMACOLOGIA / QUIMICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Índia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzotiazóis / Mutagênicos / Mycobacterium tuberculosis / Nitrocompostos / Antituberculosos Idioma: En Revista: ChemMedChem Assunto da revista: FARMACOLOGIA / QUIMICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Índia